ConductScience.org, home

Paper228940

Establishment and characterization of a cell line of human breast carcinoma origin.

Keydar I and 7 others. Eur J Cancer (1965), 1979. Cited by 655 papers, by iCite.

Cite this record

ConductScience Library. Establishment and characterization of a cell line of human breast carcinoma origin. Papers, record 228940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/228940

Download JSON
Cell line
T-47D290 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Establishment and characterization of a cell line of human breast carcinoma origin.
PubMed
Journal
Eur J Cancer (1965)
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
655
iCite
Relative citation ratio, by iCite
15.3
iCite
Revised in PubMed
2022-03-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Keydar II
2Chen LL
3Karby SS
4Weiss FRF R
5Delarea JJ
6Radu MM
7Chaitcik SS
8Brenner HJH J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Intraductal, NoninfiltratingMajor topic
Cell LineMajor topic
Caseins
Estradiol
Female
Fluorescent Antibody Technique
Humans
Karyotyping
Microscopy, Electron
Middle Aged
Pleural Effusion
Receptors, Androgen
Receptors, Estrogen
Receptors, Glucocorticoid
Receptors, Progesterone

Source PubMed

Download CSV of topics

Cited by186

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 655 citations.

PMIDTitleJournalYearIn PapersSource
42501117Dual modulation of intracellular Ca2+ signaling by hispidulin through endoplasmic reticulum mobilization and extracellular Ca2+ entry in human breast cancer cells.J Mol Histol2026https://conductscience.org/library/papers/42501117PubMed
41336283Translocation of benzo(a)pyrene reactive metabolites across human mammary epithelial cell membranes.PLoS One2025https://conductscience.org/library/papers/41336283PubMed
41111912Multilevel classification framework for breast cancer cell selection and its integration with advanced disease models.iScience2025https://conductscience.org/library/papers/41111912PubMed
40910266Insights on the differences between two‑ and three‑dimensional culture systems in tumor models (Review).Int J Mol Med2025https://conductscience.org/library/papers/40910266PubMed
39452867Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer.Mar Drugs2024https://conductscience.org/library/papers/39452867PubMed
39060878Failure to progress: breast and prostate cancer cell lines in developing targeted therapies.Cancer Metastasis Rev2024https://conductscience.org/library/papers/39060878PubMed
38486205Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.BMC Cancer2024https://conductscience.org/library/papers/38486205PubMed
38408073Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.PLoS One2024https://conductscience.org/library/papers/38408073PubMed
38391914Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes.Cells2024https://conductscience.org/library/papers/38391914PubMed
38172946Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway.J Transl Med2024https://conductscience.org/library/papers/38172946PubMed
37111093Comparison of Three Low-Molecular-Weight Fluorescent Probes for Measuring Free Zinc Levels in Cultured Mammary Cells.Nutrients2023https://conductscience.org/library/papers/37111093PubMed
36992834
Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist.
Front Pharmacol2023https://conductscience.org/library/papers/36992834PubMed
36893152Effects of β-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells.PLoS One2023https://conductscience.org/library/papers/36893152PubMed
36727068Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses.Front Oncol2022https://conductscience.org/library/papers/36727068PubMed
36600151The genomic regulation of metastatic dormancy.Cancer Metastasis Rev2023https://conductscience.org/library/papers/36600151PubMed
35897723Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding.Int J Mol Sci2022https://conductscience.org/library/papers/35897723PubMed
35668111Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor.Nat Commun2022https://conductscience.org/library/papers/35668111PubMed
35205789Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes.Cancers (Basel)2022https://conductscience.org/library/papers/35205789PubMed
34680281Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34680281PubMed
34680243[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.Cancers (Basel)2021https://conductscience.org/library/papers/34680243PubMed

See all 186 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/228940

GET https://conductscience.org/api/papers/v1/228940/cited_by?page=2